ResMed Inc share price logo

ResMed Inc

NYSE: RMD

Large Cap

$209.39

+4.37

(+2.13%)

as on

ResMed Inc Stock Performance

as on May 5, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $204.42
    $209.62
    downward going graph

    2.37%

    Downside

    0.11%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $198.64
    $293.81
    downward going graph

    5.13%

    Downside

    40.32%

    Upside

    downward going graph

ResMed Inc share price movements today

Previous Close
$205.02
Open
$205.00
Volume
1.9M
Day's Low - High
$204.42 - $209.62
52 Week Low - High
$198.64 - $293.81

ResMed Inc Historical Returns

1 Month Return
-8.51 %
3 Month Return
-23.23 %
1 Year Return
-14.81 %
3 Year Return
-11.5 %
5 Year Return
+ 6.45 %

ResMed Inc Stock Fundamentals & Key Indicators

Check ResMed Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$29.9B

EPS (TTM)

11.1235

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.10%

PE Ratio (TTM)

19.77

Industry PE ratio

28.054

PEG Ratio

1.2631

EBITDA

2.1B

Revenue (TTM)

5.5B

Profit Margin

27.44%

Return On Equity TTM

25.25%

ResMed Inc Stock Valuation

Track how ResMed Inc P/E has moved over time to understand its valuation trends.

ResMed Inc in the last 5 years

  • Overview

  • Trends

Lowest (22.59x)

December 31, 2023

Today (19.77x)

May 5, 2026

Industry (28.05x)

May 5, 2026

Highest (49.09x)

September 30, 2021

LowHigh

Today’s Price to Earnings Ratio: 19.77x

ResMed Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ResMed Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$29.9B6.45%19.7727.44%
BUY$162.1B63.8%55.5628.15%
BUY$37.0B5.78%37.429.42%
BUY$42.5B-40.22%24.48.01%
NA$37.8BNA31.294.08%

Stock Returns calculator for ResMed Inc Stock including INR - Dollar returns

The ResMed Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

ResMed Inc investment value today

Current value as on today

₹98,126

Returns

-₹1,874

(-1.87%)

Returns from ResMed Inc Stock

-₹12,993 (-12.99%)

Dollar Impact

₹11,119 (+11.12%)

Analyst Recommendation on ResMed Inc Stock

Based on 19 analysts

BUY

63.16%

Buy

36.84%

Hold

0.00%

Sell

Based on 19 analysts, 63.16% of analysts recommend a 'BUY' rating for ResMed Inc. Average target price of $270.6

ResMed Inc Share Price Target

Get share price movements and forecasts by analysts on ResMed Inc.

What analysts predicted

22.62%UPSIDE

Target Price

$270.6

Current Price

$209.39

Analyzed by

19 Analysts

Target

$270.60

ResMed Inc target price $270.6, a slight upside of 22.62% compared to current price of $209.39. According to 19 analysts rating.

ResMed Inc Stock’s Investor Sentiment and Interest

Search interest for ResMed Inc Stock has increased by 59% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:59% versus previous 30 day period

ResMed Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
1,162
1,196
1,223
1,224
1,282
1,291
1,347
1,335
1,422
1,431
Gross Profit
669
681
704
717
751
766
820
820
884
890
Operating Income
275
374
381
387
417
426
454
446
497
499
EBITDA
377
429
362
442
479
469
532
503
566
499
Interest Expense
13
14
9
5
4
3
5
8
7
12
Depreciation
53
54
54
53
55
51
74
57
62
69
Income Before Tax
259
375
357
383
418
417
458
446
496
502
Income Tax Expense
50
74
65
72
73
52
78
98
103
103
Net Income
208
300
292
311
344
365
379
348
392
398
Net Profit Margin
17.96%
25.10%
23.89%
25.43%
26.88%
28.26%
28.17%
26.10%
27.59%
27.86%

ResMed Inc Annual Profit & Loss

All numbers in Millions USD

Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
1,838
2,066
2,340
2,606
2,957
3,196
3,578
4,222
4,685
5,146
Gross Profit
1,066
1,201
1,362
1,536
1,717
1,839
2,024
2,355
2,655
3,054
Operating Income
428
425
541
579
809
903
1,000
1,131
1,319
1,685
EBITDA
540
568
680
705
990
1,103
1,176
1,358
1,533
1,913
Interest Expense
11
28
28
36
40
23
22
47
45
12
Depreciation
-
112
119
150
181
191
193
197
216
235
Income Before Tax
439
418
521
518
733
883
960
1,101
1,264
1,677
Income Tax Expense
87
76
205
114
111
409
181
204
243
276
Net Income
352
342
315
404
621
474
779
897
1,020
1,400
Net Profit Margin
19.17%
16.56%
13.49%
15.52%
21.02%
14.84%
21.78%
21.25%
21.79%
27.22%

ResMed Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
300
292
311
344
365
379
348
392
398
Operating Cash Flow
402
440
325
308
578
538
457
339
554
Investing Cash Flow
-33
-46
2
-36
-31
-133
-52
-50
-58
Financing Cash Flow
-335
-393
-150
-147
-144
-163
-230
-258
-255
Change in Cash
27
0
188
95
410
276
174
33
243

ResMed Inc Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
342
315
404
621
474
779
897
1,020
1,400
Operating Cash Flow
414
505
459
802
736
351
693
1,401
1,751
Investing Cash Flow
-81
-101
-1,075
-179
-158
-229
-1,159
-269
-200
Financing Cash Flow
-262
-1,026
580
-317
-764
-128
422
-1,119
-606
Change in Cash
90
-633
-41
316
-167
-21
-45
10
971

Mutual Funds that own ResMed Inc Stock

Check out the Mutual Funds with significant holdings in ResMed Inc.

Funds
Holdings
Shares Held
Motilal Oswal S&P 500 Index Fund Direct Growth
Motilal Oswal S&P 500 Index Fund Direct Growth
0.05828%
1088

Global Institutional Holdings in ResMed Inc

Funds
Holdings
Northern Trust Corp
1.23%
Squarepoint Ops LLC
0.37%
First Trust Advisors L.P.
1.04%
HSBC Holdings PLC
0.45%
Amvescap Plc.
1.45%

ResMed Inc News & Key Events

  • img

    Today's Timeline - 02 May

    Sat, 07:29 PM

    -

    ResMed's Q3 revenue reached $1.43bn, beating expectations, with improved profitability and strong demand in sleep apnea market.

    Sat, 11:18 PM

    -

    ResMed reports net cash position of $817.3 million, with strong growth and profitability metrics over the past five years.

Insights on ResMed Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 1.33B → 1.43B (in $), with an average increase of 3.4% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 348.53M → 398.73M (in $), with an average increase of 6.4% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, RMD has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, ResMed Inc. has experienced a drawdown of -13.0%, however Becton, Dickinson and Company resisted the overall trend and outperformed by 0.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, RMD stock has moved down by -6.5%

About ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
OrganisationResMed Inc
Headquarters9001 Spectrum Center Boulevard, San Diego, CA, United States, 92123
IndustryMedical Instruments & Supplies
CEOMr. Michael J. Farrell BE, MBA, SM
E-voting on sharesClick here to vote

Key Management of ResMed Inc

Name

Title

Mr. Michael J. Farrell BE, MBA, SM

CEO & Chairman

Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD

Founder, Chair Emeritus & Non-Executive Director

Mr. Brett A. Sandercock

Chief Financial Officer

Mr. Michael J. Rider

Chief Legal Officer & Secretary

Mr. Justin Leong

Chief Product Officer

Mr. Alastair Robertson

Chief Information Officer

Mr. Jim Ellis

Chief Compliance Officer

Ms. Sallilyn Schwartz

Chief Investor Relations Officer

Ms. Yvonne-Katrin Pucknat

Chief Marketing Officer

Ms. Vered Keisar

Chief People Officer

FAQs

What is ResMed Inc share price today?

ResMed Inc share price today is $209.39 as on at the close of the market. ResMed Inc share today touched a day high of $209.62 and a low of $204.42.

What is the 52 week high and 52 week low for ResMed Inc share?

ResMed Inc share touched a 52 week high of $293.81 on and a 52 week low of $198.64 on . ResMed Inc stock price today i.e. is closed at $209.39,which is 28.73% down from its 52 week high and 5.41% up from its 52 week low.

What is ResMed Inc's market capitalisation today?

ResMed Inc market capitalisation is $0.03T as on .

How to invest in ResMed Inc Stock (RMD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for ResMed Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ResMed Inc Shares that will get you 0.0072 shares as per ResMed Inc share price of $209.39 per share as on May 5, 2026 at 1:29 am IST.

What is the minimum amount required to buy ResMed Inc Stock (RMD) from India?

Indian investors can start investing in ResMed Inc (RMD) shares with as little as ₹95.067 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹950.67 in ResMed Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on ResMed Inc share’s latest price of $209.39 as on May 5, 2026 at 1:29 am IST, you will get 0.0478 shares of ResMed Inc. Learn more about fractional shares .

What are the returns that ResMed Inc has given to Indian investors in the last 5 years?

ResMed Inc stock has given 6.45% share price returns and 28.65% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?